{"filings":[{"id":99189,"accession_number":"0001193125-26-208934","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q3 revenue drops 25%; EPS falls to $0.11; guidance lowered","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $43.7M, down 25.2% YoY; Americas down 28.9%, Asia/Pacific & Europe down 7.7%.","Net income $1.4M ($0.11 diluted EPS) vs $3.5M ($0.26) prior year; adjusted EPS $0.12.","Adjusted EBITDA $3.2M, halved from $6.4M; operating income $1.7M vs $4.1M.","Dividend raised 11.1% to $0.05/share, payable June 15, 2026 to holders of record June 1.","Fiscal 2026 guidance expected near lower end of prior range; no specific numbers provided."],"consensus_eps_estimate":null,"consensus_eps_actual":0.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":140209000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99188,"accession_number":"0001193125-26-159324","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"LifeVantage names Terrence Moorehead CEO; current CEO Steve Fife retiring Apr 30","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve Fife retires as President and CEO effective April 30, 2026; transition agreement with advisory through Sept 11, 2026.","Terrence Moorehead appointed President, CEO and Board member effective August 5, 2026; formerly CEO of Nature's Sunshine Products 2018-2025.","Michael Beindorff appointed Interim CEO from May 1 to Aug 4, 2026; paid $45,833/month under consulting agreement.","Moorehead compensation: $850k base salary; annual cash bonus target up to 100%; RSUs of $2M (3-yr vest) + $800k prorated; PSUs of $3.5M + $1.2M (revenue/EBITDA targets).","Transition benefits for Fife: medical premiums up to 18 months, prorated FY2026 bonus, continued RSU/PSU vesting through transition term."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115057,"accession_number":"0001628280-26-005431","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"LifeVantage Q2 revenue drops 27.8% to $48.9M; CEO Fife to retire in April","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $48.9M, down 27.8% YoY; Americas revenue fell 32.6%.","GAAP EPS $0.02 vs $0.19; adjusted EPS $0.15 vs $0.22; adjusted EBITDA $3.9M vs $6.5M.","Inventory obsolescence charge of $2.4M for MindBody GLP-1 System weighed on gross margin.","New $60M share repurchase authorization approved; quarterly dividend $0.045/share.","CEO Steve Fife to retire in April 2026; board conducting executive search."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":96493000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131447,"accession_number":"0001628280-25-055939","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"LifeVantage CMO and CIO resign, effective Dec 12 and Dec 24, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CMO Julie Boyster resigns effective December 12, 2025 to pursue other opportunities.","CIO Todd Thompson resigns effective December 24, 2025 to pursue other opportunities.","No replacements have been announced for either officer role.","Departures were disclosed in an 8-K filed December 8, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131446,"accession_number":"0001628280-25-051641","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"LifeVantage FY2026 annual meeting results: all proposals approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected; Beindorff, Greer, Lewis received >1.9M against votes and 1.87M broker non-votes.","Advisory say-on-pay approved with 7.42M for vs 246k against (broker non-votes 1.87M).","Ratification of Deloitte as auditor passed with 9.54M for, 31k against.","Amendment to 2017 Long-Term Incentive Plan approved: 5.38M for, 2.31M against, 1.87M broker non-votes.","Turnout: 9.57M shares voted (75.4% of outstanding)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131445,"accession_number":"0001628280-25-048801","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q1 FY2026 revenue $47.6M (+0.7%), EPS $0.17 vs $0.14 a year ago","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $2.2M ($0.17 diluted EPS); adjusted EPS $0.18 vs $0.15.","Adjusted EBITDA $3.9M, down from $4.4M a year earlier.","Americas revenue +0.8%; Asia/Pacific & Europe revenue +0.4% (constant currency -1.4%).","Declared $0.045/share cash dividend payable Dec 15, 2025 to holders of record Dec 1, 2025.","Reaffirmed FY2026 guidance: revenue $225-240M, adj. EBITDA $23-26M, adj. EPS $1.00-1.15."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":47561000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148028,"accession_number":"0000849146-25-000069","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q4 revenue $55.1M (+12.6% YoY); full-year EPS $0.75 vs $0.23","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $55.1M (+12.6%); net income $0.15 diluted EPS (adjusted $0.17).","FY25 revenue $228.5M (+14.2%); net income $0.75 diluted EPS vs $0.23; adjusted EPS $0.82.","FY25 adjusted EBITDA $22.1M (+30.3% YoY); Q4 flat at $4.8M.","FY2026 guidance: revenue $225-240M, adjusted EBITDA $23-26M, adjusted EPS $1.00-1.15.","Declared dividend $0.045/share payable Sept 16, 2025; repurchased 0.3M shares for $3.1M in FY25."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166768,"accession_number":"0000849146-25-000041","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q3 revenue $58.4M (+21% YoY); EPS $0.26 vs $0.13","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $3.5M ($0.26 diluted EPS) vs $1.7M ($0.13) a year ago; adjusted EPS also $0.26 vs $0.21.","Americas revenue rose 29.5%; Asia/Pacific & Europe fell 7.2% (down 4.7% constant currency).","Gross margin improved 210 bps to 81.0%; adjusted EBITDA $6.4M vs $5.1M.","FY2025 guidance: revenue $228-235M, adjusted EBITDA $21-24M, adjusted EPS $0.72-0.88; quarterly dividend $0.045."],"consensus_eps_estimate":0.1887,"consensus_eps_actual":0.6,"consensus_revenue_estimate":null,"consensus_revenue_actual":173416000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184182,"accession_number":"0000849146-25-000015","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2025-02-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q2 revenue up 31% to $67.8M; raises FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $67.8M (+31.3% YoY); Americas +46.3%, APAC/Europe -15.5%.","Net income $0.19 diluted EPS vs loss $0.05; adjusted EPS $0.22 vs $0.10.","Adjusted EBITDA $6.5M vs $3.1M; operating income $3.4M vs loss $1.3M.","FY2025 guidance raised: revenue $235-245M, adj EBITDA $21-24M, adj EPS $0.72-0.88.","Declares $0.04/share dividend payable March 17, 2025; record March 3."],"consensus_eps_estimate":0.1581,"consensus_eps_actual":0.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":114976000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200765,"accession_number":"0000849146-24-000146","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"LifeVantage eliminates Series A Preferred Stock after Rights Agreement expired","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Rights Agreement expired Aug 28, 2024; stock purchase rights terminated.","Certificate of Elimination filed Nov 18, 2024 with Delaware Secretary of State.","No shares of Series A Preferred Stock were issued or outstanding at filing.","Shares returned to authorized but undesignated preferred stock pool.","No impact on common stock rights or company operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200764,"accession_number":"0000849146-24-000142","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-11-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"LifeVantage annual meeting results: all eight directors elected, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 8 director nominees elected; votes ranged from 5.59M to 6.19M for.","Say-on-pay approved: 4.56M for, 1.61M against, 30k abstain.","Ratification of Deloitte as auditor approved with 8.7M for, 81k against.","Shareholders set say-on-pay frequency to every year (5.84M for every year)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200763,"accession_number":"0000849146-24-000122","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q1 revenue falls 8.1% to $47.2M; net income rises to $0.14 diluted EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $0.14 diluted EPS vs $0.05 a year ago; adjusted EPS $0.15 vs $0.13.","Americas revenue down 4.2%; Asia/Pacific & Europe down 19.7% (18.7% constant currency).","Adjusted EBITDA rose 11% to $4.4M from $4.0M; margin improved 160 bps.","FY2025 guidance reaffirmed: revenue $200M-$210M, adj. EBITDA $18M-$21M, adj. EPS $0.70-$0.80.","Declared $0.04 dividend payable Dec 16, record Dec 2; repurchased 0.1M shares for $1.1M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":47214000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216781,"accession_number":"0000849146-24-000074","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-08-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q4 rev down 9.8% to $48.9M; FY adj EPS $0.59; FY25 guidance $200-210M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP EPS $0.10; adjusted EPS $0.14; revenue down 9.8% YoY to $48.9M.","FY2024 revenue $200.2M (-6.2%); adj EBITDA $17.0M (+44.7%); GAAP EPS $0.23 vs $0.20.","Declared $0.04 dividend payable Sep 17, record Sep 9; cash $16.9M, no debt.","FY2025 guidance: rev $200-210M, adj EBITDA $18-21M, adj EPS $0.70-0.80.","Americas rev -4.1%; Asia/Pacific & Europe -25.2% in Q4, impacted by forex."],"consensus_eps_estimate":null,"consensus_eps_actual":0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":200164000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216780,"accession_number":"0000849146-24-000064","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Erin Brockovich resigns from LifeVantage board; Rajendran Anbalagan appointed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Erin Brockovich resigned from LifeVantage board effective Aug 26, 2024; not due to any disagreement.","Rajendran Anbalagan appointed to board effective immediately; will serve on Nominating and Corporate Governance Committee.","Anbalagan brings digital/technology expertise; chosen to enhance customer experience and growth strategy.","He will receive initial restricted stock award of $105,000 prorated and standard non-employee director compensation.","Company entered indemnification agreement with Anbalagan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236490,"accession_number":"0000849146-24-000048","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"LifeVantage Q3 revenue falls 10.2% to $48.2M; guidance cut; adjusted EBITDA up 55%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $48.2M, down 10.2% YoY; Americas -5.9%, Asia/Pacific & Europe -22.4% (constant currency -16.1%).","GAAP EPS $0.13, adjusted EPS $0.21 vs $0.08 a year ago; adjusted EBITDA $5.1M, up 54.7%.","Fiscal 2024 revenue guidance lowered to $202-205M from $207-213M; adjusted EBITDA guidance unchanged at $16-18M.","Declared $0.04/share cash dividend payable June 14, 2024 to holders of record May 31, 2024.","Repurchased 0.3M shares for $1.9M in Q3; $22.3M remaining under buyback program; cash $17.4M, no debt."],"consensus_eps_estimate":null,"consensus_eps_actual":0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":151233000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236489,"accession_number":"0000849146-24-000039","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-04-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"LifeVantage enters $5M revolving credit facility with Bank of America, matures 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving line of credit up to $5,000,000 with Bank of America; interest at Term SOFR + 2.00% (floor 0.00%).","Facility matures April 12, 2027; monthly interest payments starting May 31, 2024; principal due at maturity.","Obligations secured by substantially all assets of LifeVantage and guaranteed by subsidiary Lifeline Nutraceuticals Corporation.","Includes up to $1,000,000 sublimit for stand-by letters of credit; 2.00% p.a. fee on undrawn amounts.","New facility replaces prior revolving credit agreement with Zions Bancorporation, which was discharged concurrently."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":254129,"accession_number":"0000849146-24-000021","cik":849146,"company_name":"Lifevantage Corp","ticker":"LFVN","form_type":"8-K","filed_at":"2024-02-15T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"LifeVantage appoints Dayton Judd to board under cooperation agreement with activist investors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Appointed Dayton Judd to Board; Board size increased by one seat.","Cooperation Agreement with Radoff-Sudbury Group (owns ~12.6% of LFVN) resolves books-and-records demand.","Standstill and voting commitments; Judd also on Audit and Nominating Committees.","Management reaffirms LV360 strategy targeting double-digit Adjusted EBITDA margins.","No financial terms disclosed; agreement ends before FY2027 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":101557363.08080809,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}